Clinical technology review · 2026
AI-Assisted PACS for MFM
A physician’s guide to buying image intelligence without buying ambiguity.
Chukwuma Onyeije, MD · Maternal-Fetal Medicine
DICOMAI QAREPORTEHR
The purchasing decision
Buy a validated workflow, not an AI label.
Clinical
value
value
Classify
Verify
Validate
Monitor
Category clarity
Five layers hide inside “AI PACS.”
01ArchivePACS
02ReportingViewPoint
03Console AISonoLyst
04Image QASonio Detect
05Report AIPowerScribe
Workflow timing
The best correction happens before the patient leaves.
Order
Acquire
Validate
Archive
Interpret
Report
Audit
Recoverability windowMissing views remain fixable during acquisition.
AIUM: permanent, retrievable images must permit later review for diagnostic adequacy. Documentation parameter
Claim discipline
Image validation is not anomaly detection.
Recognize
Which plane?
Verify
Meets criteria?
Measure
Where are calipers?
Detect
Possible abnormality?
Evidence-corrected shortlist
Five names. Four categories.
Candidate
Primary layer
Philips UWS
Review
GE stack
Console + report
Samsung stack
Console + sharing
PowerScribe
Report
Sonio Detect
Concurrent QA
Philips
Ultrasound Workspace
Fit for stated use
Verified
Fetal review, quantification, reporting, integrationDo not infer
Real-time fetal QA or anomaly detectionPhilips UWS is indicated for fetal quantification/reporting; named AI functions in the verified IFU are chiefly cardiac. UWS 7.0 IFU · K241659
GE HealthCare
ViewPoint + SonoLyst
Fit for Voluson sites
Console
Real-time view recognition and quality supportDepartment
MFM reporting and image workflowGE describes SonoLyst as Voluson AI and ViewPoint 6 as women’s-health reporting connected to PACS/EHR. SonoLyst · ViewPoint 6
Samsung Medison
Separate clinical AI from HelloMom.
Two different purposes
Clinical console
BiometryAssist · ViewAssist · HeartAssistPatient app
HelloMom is non-diagnosticSamsung documents Intelligent Assist on ultrasound systems; HelloMom labeling states it cannot be used for medical purposes. Samsung clinical AI · HelloMom labeling
Microsoft
PowerScribe One
Fit for image validation
Strong
Reporting, quality checks, AI orchestrationNot established
Fetal plane or exam-completeness validationMicrosoft positions PowerScribe One as radiology reporting with AI findings, guidance, and quality checks. PowerScribe One · PowerCast guide
Sonio · Samsung
Sonio Detect
Fit for stated use
FDA-cleared
Concurrent fetal view,anatomy, and quality analysis
Bounded
Version, views, criteria, protocol coverageSonio Detect v3 is a concurrent reading aid for fetal images and clips; the FDA summary reports 14 T1 and 40 T2/T3 detected views. FDA K252433
Regulatory precision
Clearance answers one bounded question.
510(k)
Trade name
Version
Intended use
Users
Population
Outputs
Human review
Limitations
It does not prove local performance, interoperability, superiority, or ROI.
FDA clearance is device- and indication-specific. Verify the decision summary, not the brand’s umbrella language. FDA 510(k) overview
Local evidence
Vendor accuracy is not your site’s accuracy.
BMI
Gestational age
Anomalies
Multiple gestation
Operators
Ultrasound vendors
Prospective go / no-go
FDA emphasizes representative datasets and continuing performance evaluation as AI-enabled devices evolve. FDA performance evaluation
Interoperability
Integration failure can erase model performance.
Worklist
Acquire
DICOM
AI
Report
EHR
Wrong accession
Missing cine
Silent downtime
Require conformance statements and test actual data flow. DICOM Standard · AIUM documentation
Buy evidence. Keep control.
Triangles mark non-negotiable evidence and control.
Criteria
Procurement domains
Clinical
Mixed fleet
Security
Operations
Exit
Intended-use match
!
−
−
✓
−
Site validation
!
✓
−
✓
−
Interoperability
✓
!
✓
✓
✓
Data/model terms
✓
−
!
✓
!
!Critical✓Standard−Low/N/A
Implementation algorithm
Pilot the workflow before enterprise commitment.
01Define use
02Baseline
03Silent mode
04Validate
05Train
06Launch narrow
07Monitor
Post-deployment monitoring
Measure patient care, not clicks.
Incomplete exams
↓
Recalls
%
Overrides
↺
Turnaround
min
Equity
Δ
Clinical pearls
Buy the boundary, not the brand.
01Classify first
02Read labeling
03Keep human review
04Validate locally
05Test downtime
06Monitor drift
07Audit overrides
08Protect exit rights
Evidence remains smaller than marketing.
Known
- QA can standardize acquisition.
- Clearance is function-specific.
Uncertain
- Outcome improvement
- Generalizability
- Long-term ROI
Disputed
- Automation bias
- Vendor lock-in
- Liability allocation
Make the purchase auditable
References +
purchaser checklist
Exact intended use
Supported views and populations
Local validation plan
DICOM, HL7, FHIR behavior
Monitoring and exit rights
Educational review, not legal, regulatory, or purchasing advice. Product availability and labeling change; verify current documentation before contracting.